From: Volumetric and MGMT parameters in glioblastoma patients: Survival analysis
 | Overall Survival | Progression-free Survival | ||||
---|---|---|---|---|---|---|
 | HR | 95% CI | p | HR | 95% CI | Wald-p |
Age | Â | Â | Â | Â | Â | Â |
   < 50 | 1 | - |  |  |  |  |
   ≥ 50 | 1.74 | 0.91-3.30 | 0.092 |  |  |  |
PS | Â | Â | Â | Â | Â | Â |
   0 | 1 | - |  | 1 |  |  |
   1 or 2 | 2.01 | 1.15-3.51 | 0.014 | 2.88 | 1.66-5.01 | < 0.001 |
Sex | Â | Â | Â | Â | Â | Â |
   Female |  |  |  | 1 |  |  |
   Male |  |  |  | 1.61 | 0.93-2.79 | 0.090 |
PreOp Necrosis | Â | Â | Â | 1.02 | 1.00-1.04 | 0.030 |
PreOp Enhancing tumor | 1.01 | 1.00-1.02 | 0.066 | Â | Â | Â |
PreRCT Net-enhancing tumor | 1.02 | 1.00-1.04 | 0.023 | Â | Â | Â |